Stocks股票 / Health Care / IART
IART US listed · USD美股 · 美元
Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery.Integra LifeSciences Holdings Corporation是一家全球医疗设备制造公司,总部位于新泽西州普林斯顿,成立于1989年,生产用于皮肤再生、神经外科、重建和普通外科的产品。
Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-07-21Earnings财务业绩
next report下次财报 2026-07-30Estimates being raised — 2 analysts预期上调 — 2 位分析师
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | IART | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 1.41x | 3.44 | |
| P/S市销率 | 0.90x | 2.97 | |
| Earnings yield盈利收益率 | -35.12% | 2.72 | |
| FCF yield自由现金流收益率 | -2.11% | 4.00 | |
| Shareholder yield股东收益率 | 0.02% | 1.89 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: +$0.1M net (1 buyers, 0 sellers)+$0.1M 净值(1 买家,0 卖家)
Signal history信号历史
engine events引擎事件Company profile公司档案
Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery.Integra LifeSciences Holdings Corporation是一家全球医疗设备制造公司,总部位于新泽西州普林斯顿,成立于1989年,生产用于皮肤再生、神经外科、重建和普通外科的产品。
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 1.4× | 3.4× | 89% |
| Price / Sales市销率 | 0.9× | 3.0× | 84% |
| Earnings yield盈利收益率 | -35.1% | 2.7% | 4% |
| Free-cash-flow yield自由现金流收益率 | 3.4% | 5.5% | 28% |
| Shareholder yield股东综合回报率 | 0.0% | 1.9% | 12% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +1.7% | -0.9% |
| 1 Month近1月 | +7.5% | -0.6% |
| 3 Months近3月 | +79.6% | +5.4% |
| 6 Months近6月 | +55.0% | +8.6% |
| Year to date年初至今 | +57.3% | +8.9% |
| 1 Year近1年 | +69.7% | +19.2% |
| 3 Years近3年 | -58.4% | +69.9% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $1.4B | $1.5B | $1.6B | $1.5B | $1.6B | $1.6B |
| EPS每股收益 | $1.57 | $1.98 | $2.16 | $0.84 | $-0.09 | $-6.74 |
| Free cash flow自由现金流 | $165M | $264M | $222M | $73M | $25M | $-31M |
| Gross margin毛利率 | 62.0% | 61.2% | 62.3% | 57.4% | 54.8% | 50.9% |
| Net margin净利率 | 9.8% | 11.0% | 11.6% | 4.4% | -0.4% | -31.6% |
| FCF margin自由现金流利润率 | 12.0% | 17.1% | 14.3% | 4.7% | 1.6% | -1.9% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量:盈利有现金支撑
- Working capital: inventory +59% vs sales +19% — inventory building, demand risk营运资本:存货 +59% 对销售 +19%——存货积压,需求风险
- Pricing power: gross margin −11.1pts over 6 years定价能力:毛利率 6 年下降 11.1 个百分点
- Capital discipline: investment near the peer median资本纪律:投资力度接近同业中位
- Balance sheet: Altman Z 0.75 — distress zone资产负债表:Altman Z 0.75——困境区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Estimate revisions预期修正
Insiders & shorts内部人与空头
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -7.8% | 3 |
| Feb2月 | 33% | -7.1% | 3 |
| Mar3月 | 0% | -4.6% | 3 |
| Apr4月 | 33% | -18.7% | 3 |
| May5月 | 67% | +8.7% | 3 |
| Jun6月 | 25% | -0.6% | 4 |
| Jul7月 | 75% | +8.6% | 4 |
| Aug8月 | 33% | -6.5% | 3 |
| Sep9月 | 0% | -10.4% | 3 |
| Oct10月 | 33% | -5.7% | 3 |
| Nov11月 | 100% | +10.0% | 3 |
| Dec12月 | 33% | -5.0% | 3 |